{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:02:26Z","timestamp":1784070146971,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.bpg.2006.10.004","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:39:38Z","timestamp":1168994378000},"page":"111-123","source":"Crossref","is-referenced-by-count":46,"title":["Diagnosis and treatment of acute renal failure in patients with cirrhosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Richard","family":"Moreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lebrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2006.10.004_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-123-8-199510150-00007","article-title":"Diagnosing vascular causes of renal failure","volume":"123","author":"Abuelo","year":"1995","journal-title":"Ann Intern"},{"key":"10.1016\/j.bpg.2006.10.004_bib3","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(95)92057-9","article-title":"Acute renal failure","volume":"346","author":"Brady","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199605303342207","article-title":"Acute renal failure","volume":"334","author":"Thadhani","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","article-title":"Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study","volume":"50","author":"Moreau","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2006.10.004_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1478-3231.2005.01188.x","article-title":"Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial","volume":"26","author":"Moreau","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2006.10.004_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000187513","article-title":"Renal hemodynamic in patients with cirrhosis: relationship with ascites and liver failure","volume":"65","author":"Moreau","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.bpg.2006.10.004_bib12","series-title":"Portal hypertension III. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies","first-page":"168","article-title":"Baveno III consensus statements: treatment of the acute bleeding episode","author":"Bosch","year":"2001"},{"key":"10.1016\/j.bpg.2006.10.004_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/jhep.2001.27830","article-title":"Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis","volume":"34","author":"Cardenas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","author":"American College of Chest Physicians-Society of Critical Care Medicine Consensus Conference","year":"1992","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis","volume":"35","author":"Fernandez","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib17","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.21094","article-title":"The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond","volume":"43","author":"Moreau","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with non-steroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.44.2.270","article-title":"Anti-inflammatory drugs and varceal bleeding: a case-control study","volume":"44","author":"De L\u00e9dinghen","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2006.10.004_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The COXIBS, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199411243312111","article-title":"Prevention of nephrotoxicity induced by radiocontrast agents","volume":"331","author":"Barrett","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib25","first-page":"800","article-title":"Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis","volume":"17","author":"Salmeron","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib26","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0016-5085(01)81028-3","article-title":"Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive \u03b2-blockers","volume":"121","author":"Garcia-Pagan","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0016-5085(93)90431-B","article-title":"Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver","volume":"104","author":"Gentilini","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/gast.2001.26288","article-title":"Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis","volume":"121","author":"Gonzalez-Abraldes","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/gast.2001.26295","article-title":"Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension","volume":"121","author":"Schepke","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.10.004_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00005792-199503000-00001","article-title":"The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature","volume":"74","author":"Montseny","year":"1995","journal-title":"Medicine"},{"key":"10.1016\/j.bpg.2006.10.004_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","article-title":"Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis","volume":"54","author":"D'Amico","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.bpg.2006.10.004_bib32","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(98)06195-9","article-title":"Glomerulonephritis","volume":"353","author":"Couser","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.510240527","article-title":"Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities","volume":"24","author":"Jou\u00ebt","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","article-title":"Effect of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study","volume":"357","author":"Schortgen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib35","doi-asserted-by":"crossref","unstructured":"Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med; 345: 588\u2013895.","DOI":"10.1056\/NEJMra002709"},{"key":"10.1016\/j.bpg.2006.10.004_bib36","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(00)03495-4","article-title":"Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.1840140313","article-title":"Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis","volume":"14","author":"Bacq","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1084","article-title":"Such stuff as dreams are made on: mediator-directed therapy in sepsis","volume":"2","author":"Marshall","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bpg.2006.10.004_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C\u00a0for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib41","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","article-title":"Septic shock","volume":"365","author":"Annane","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.21101","article-title":"Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock","volume":"43","author":"Tsai","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/cs0920433","article-title":"The hepatorenal syndrome","volume":"92","author":"Moore","year":"1997","journal-title":"Clin Sci"},{"key":"10.1016\/j.bpg.2006.10.004_bib45","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/jhep.2001.29200","article-title":"New challenge of hepatorenal syndrome: prevention and treatment","volume":"34","author":"Wong","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1440-1746.2002.02778.x","article-title":"Hepatorenal syndrome in patients with cirrhosis","volume":"17","author":"Moreau","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2006.10.004_bib47","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2006.10.004_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jhep.2003.10.024","article-title":"The growing evidence that renal function should be improved in patients with cirrhosis and hepatorenal syndrome before liver transplantation","volume":"40","author":"Moreau","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2006.10.004_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-8278(00)80459-6","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2006.10.004_bib51","first-page":"15","article-title":"Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study","volume":"64","author":"Mulkay","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.bpg.2006.10.004_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042737-200202000-00009","article-title":"Effect of terlipressin (Glypressine) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study","volume":"14","author":"Halimi","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2006.10.004_bib53","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, non-randomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2006.10.004_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type 1 hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib56","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2006.10.004_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2006.10.004_bib59","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199703203361203","article-title":"Anaritide in acute tubular necrosis","volume":"336","author":"Allgren","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib60","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/ajkd.2000.17659","article-title":"Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal failure Study Group","volume":"36","author":"Lewis","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bpg.2006.10.004_bib61","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa020074","article-title":"Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam","volume":"347","author":"Phu","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib62","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1681\/ASN.V12suppl_1s40","article-title":"What is the renal replacement method of first choice for intensive care patients?","volume":"12","author":"Vanholder","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bpg.2006.10.004_bib63","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1523-1755.2001.0600031154.x","article-title":"A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure","volume":"60","author":"Mehta","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.bpg.2006.10.004_bib64","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(99)00298-6","article-title":"Does biocompatibility of dialysis membranes affect recovery of renal function and survival?","volume":"354","author":"Vanholder","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(00)02430-2","article-title":"Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial","volume":"356","author":"Ronco","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.10.004_bib66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa010877","article-title":"Daily hemodialysis and the outcome of acute renal failure","volume":"346","author":"Schiffl","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/jlts.2002.32504","article-title":"Identification of patients best suited for combined liver-kidney transplantation","volume":"8","author":"Davis","year":"2002","journal-title":"Part II. Liver Transpl"},{"key":"10.1016\/j.bpg.2006.10.004_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM200007203430311","article-title":"Acetylcysteine and nephrotoxic effects of radiographic contrast agents \u2013 a new use for an old drug","volume":"343","author":"Safirstein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2006.10.004_bib69","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"N Engl J Med"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169180600134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169180600134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T18:10:13Z","timestamp":1628359813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169180600134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S152169180600134X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2006.10.004","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}